Evidence map›Paper›PMID 27075100›Full record

ArticleNature2016

Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.

Dilmi Perera, Rebecca C Poulos, Anushi Shah, Dominik Beck, John E Pimanda, Jason W H Wong

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 219 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Hotspot propensity across mutational processes.Molecular systems biology · 2024
    Article
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dilmi PereraPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
Rebecca C PoulosPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
Anushi ShahPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
Dominik BeckPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
John E PimandaPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
Jason W H WongPrince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney 2052, Australia.
UNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Promoters are DNA sequences that have an essential role in controlling gene expression. While recent whole cancer genome analyses have identified numerous hotspots of somatic point mutations within promoters, many have not yet been shown to perturb gene expression or drive cancer development. As such, positive selection alone may not adequately explain the frequency of promoter point mutations in cancer genomes. Here we show that increased mutation density at gene promoters can be linked to promoter activity and differential nucleotide excision repair (NER). By analysing 1,161 human cancer genomes across 14 cancer types, we find evidence for increased local density of somatic point mutations within the centres of DNase I-hypersensitive sites (DHSs) in gene promoters. Mutated DHSs were strongly associated with transcription initiation activity, in which active promoters but not enhancers of equal DNase I hypersensitivity were most mutated relative to their flanking regions. Notably, analysis of genome-wide maps of NER shows that NER is impaired within the DHS centre of active gene promoters, while XPC-deficient skin cancers do not show increased promoter mutation density, pinpointing differential NER as the underlying cause of these mutation hotspots. Consistent with this finding, we observe that melanomas with an ultraviolet-induced DNA damage mutation signature show greatest enrichment of promoter mutations, whereas cancers that are not highly dependent on NER, such as colon cancer, show no sign of such enrichment. Taken together, our analysis has uncovered the presence of a previously unknown mechanism linking transcription initiation and NER as a major contributor of somatic point mutation hotspots at active gene promoters in cancer genomes.

Indexed as

Mutation RateTranscription Initiation, GeneticColonic NeoplasmsDeoxyribonuclease IDNA DamageDNA RepairEnhancer Elements, GeneticGene Expression Regulation, NeoplasticGenome, HumanHumansLung NeoplasmsMelanomaMutagenesisNeoplasmsPoint MutationPromoter Regions, GeneticDeoxyribonuclease I

Identifiers

PMID27075100
OpenAlexW2341025815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.